Search All News
New research from HICCC members shows that higher blood glucose levels ‘attract’ cancer cells to spread to the liver.
Research from Dr. Ciccia's lab reveals the dual mechanism of SMARCAL1, a DNA translocase, and its potential as a therapeutic target.
Spotlighting new research from the Momen-Heravi lab on immunotherapy response in head and neck cancer and other solid tumor types.
New research by the labs of Nicholas Arpaia, PhD, (pictured) and Tal Danino, PhD, marks a major step forward in efforts to enlist non-pathogenic bacteria to combat cancer.
- November 3, 2022
Results of a multi-center study, co-led by Dr. Richard Carvajal, demonstrates a promising new immunotherapy for patients with rare uveal melanoma.
- March 18, 2022
In a new content series, Notes from the Lab, we spotlight research by the Piero Dalerba lab that aims to predict resistance to immunotherapy in certain colon cancers.
- February 18, 2022
In a new study, researchers demonstrate that applying artificial intelligence to standard-of-care imaging can help predict how well immunotherapy will work for patients with melanoma.
Source:CUIMC NewsroomMarch 5, 2021
Ben Izar, MD, and colleagues have created a new technique that can uncovertricks cancer cells use to evade immunotherapies, which could lead to the development of more effective treatments.
- February 19, 2021
Meet Dr. Robyn Gartrell, a physician-scientist focused on bringing cutting-edge cancer immunotherapies that have had success in treating adult cancers to childhood cancers.
- November 24, 2020
A physician-researcher in thoracic oncology, Dr. Catherine Shu has a focused interest in improving outcomes for lung cancer patients with resectable disease.
- October 5, 2020
Dr. Kathy Crew's work in breast cancer risk, prevention, and screening has been instrumental in the advancement of breast cancer research.